Home › Funds › D. E. Shaw & Co › ADPT
D. E. Shaw & Co position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
Latest position (Q2 2026)4.63M sh
Reported value held$99.22M
Portfolio Weight0.05%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 132.20K | $1.83M | New |
| Q2 2022 | 156.18K | $1.26M | Add |
| Q3 2022 | 58.68K | $418.00K | Reduce |
| Q4 2022 | 116.18K | $887.63K | Add |
| Q1 2023 | 227.73K | $2.01M | Add |
| Q2 2023 | 87.95K | $590.13K | Reduce |
| Q3 2023 | 131.27K | $715.42K | Add |
| Q4 2023 | 41.74K | $204.54K | Reduce |
| Q2 2025 | 608.28K | $7.09M | New |
| Q3 2025 | 738.18K | $11.04M | Add |
| Q4 2025 | 1.90M | $30.90M | Add |
| Q1 2026 | 1.97M | $27.28M | Add |
| Q2 2026 | 4.63M | $99.22M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- BlackRock Inc 15.14M sh · $324.73M · Q2 2026
- Vanguard Group 11.28M sh · $183.22M · Q4 2025
- Wellington Management Group 5.91M sh · $126.80M · Q2 2026
- Geode Capital Management 3.64M sh · $78.13M · Q2 2026
- UBS Group AG 3.13M sh · $67.15M · Q2 2026
- Invesco Ltd 3.09M sh · $66.37M · Q2 2026
- Goldman Sachs Group 2.98M sh · $64.01M · Q2 2026
- Arrowstreet Capital 2.52M sh · $54.15M · Q2 2026
- ARK Invest 2.09M sh · $44.84M · Q2 2026
- Bank of America Corp 1.73M sh · $37.11M · Q2 2026